XNASMRM
Market cap6mUSD
Dec 23, Last price
1.19USD
1D
-3.01%
1Q
-66.99%
IPO
-92.02%
Name
Medirom Healthcare Technologies Inc
Chart & Performance
P/E
8.27
P/S
0.14
EPS
22.50
Div Yield, %
0.00%
Shrs. gr., 5y
1.82%
Rev. gr., 5y
14.74%
Revenues
6.83b
-1.81%
Net income
115m
-22.77%
CFO
-632m
L-7.87%
Earnings
Mar 27, 2025
Profile
MEDIROM Healthcare Technologies Inc. provides holistic healthcare services in Japan. It operates in two segments, Relaxation Salon and Digital Preventative Healthcare. The Relaxation Salon segment owns and franchises relaxation salons, which provide finger-pressure style bodywork therapy, stretch therapy, and posture and joint alignment, as well as physical therapy elements; and various individual services, including anti-fatigue therapy, athletic support therapy, slim-down therapy, and reflexology. As of December 31, 2021, this segment operated 312 relaxation salons under the Re.Ra.Ku and Ruam Ruam brand. The Digital Preventative Healthcare segment offers government-sponsored Specific Health Guidance program, utilizing Lav, its internally developed on-demand health monitoring smartphone application; MOTHER Tracker for fitness applications; and preventative healthcare services utilizing its digital application and devices. MEDIROM Healthcare Technologies Inc. also operates Re.Ra.Ku College that offers continuing training for franchise owners, home office staff, and salon staff covering topics, such as customer service, salon operations, and relaxation techniques located in the Odaiba area in Tokyo. The company was formerly known as MEDIROM Inc. and changed its name to MEDIROM Healthcare Technologies Inc. in March 2020. MEDIROM Healthcare Technologies Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
| Income | ||||||
Revenues | 6,827,943 -1.81% | 6,954,057 28.54% | 5,409,825 61.89% | |||
Cost of revenue | 7,219,522 | 5,186,727 | 4,125,373 | |||
Unusual Expense (Income) | ||||||
NOPBT | (391,579) | 1,767,330 | 1,284,452 | |||
NOPBT Margin | 25.41% | 23.74% | ||||
Operating Taxes | (94,427) | 30,809 | 576,250 | |||
Tax Rate | 1.74% | 44.86% | ||||
NOPAT | (297,152) | 1,736,521 | 708,202 | |||
Net income | 115,049 -22.77% | 148,965 -115.04% | (990,731) 83.75% | |||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | ||||||
BB yield | ||||||
| Debt | ||||||
Debt current | 1,263,837 | 99,168 | 162,252 | |||
Long-term debt | 4,483,484 | 4,344,796 | 3,759,281 | |||
Deferred revenue | ||||||
Other long-term liabilities | 687,203 | 802,359 | 889,606 | |||
Net debt | 5,558,932 | 3,784,990 | 3,491,396 | |||
| Cash flow | ||||||
Cash from operating activities | (631,737) | (685,697) | (557,231) | |||
CAPEX | (135,840) | (120,740) | (95,651) | |||
Cash from investing activities | (328,576) | 580,437 | (83,936) | |||
Cash from financing activities | 461,206 | 340,097 | (427,949) | |||
FCF | (1,114,834) | 1,133,639 | 1,602,705 | |||
| Balance | ||||||
Cash | 106,847 | 605,954 | 377,117 | |||
Long term investments | 81,542 | 53,020 | 53,020 | |||
Excess cash | 311,271 | 159,646 | ||||
Stockholders' equity | 105,359 | (1,321,834) | (1,470,799) | |||
Invested Capital | 4,552,433 | 4,526,381 | 4,189,639 | |||
ROIC | 39.85% | 17.67% | ||||
ROCE | 55.15% | 47.24% | ||||
| EV | ||||||
Common stock shares outstanding | 5,167 | 5,471 | 4,877 | |||
Price | 5.72 26.83% | 4.51 -25.48% | 6.05 -57.97% | |||
Market cap | 29,553 19.78% | 24,673 -16.42% | 29,521 -49.06% | |||
EV | 5,593,567 | 3,809,663 | 3,520,917 | |||
EBITDA | (138,984) | 1,951,386 | 1,410,695 | |||
EV/EBITDA | 1.95 | 2.50 | ||||
Interest | 36,868 | |||||
Interest/NOPBT | ||||||